Priorities
- Increase the participation and representation of diverse populations, particularly underrepresented and underserved groups, in precision oncology (e.g., clinical trials, research studies, biospecimen studies).
- Enhance culturally and linguistically appropriate community engagement and education efforts to improve cancer prevention, early detection and diagnosis, and survivorship in diverse communities, including underrepresented and medically underserved groups.
- Promote culturally competent training in areas such as cancer and cancer health disparities (CHD) research, social sciences, behavioral research, clinical practice, and allied health professions.
- Advance the translation of cancer -omics and precision medicine to reduce disparities and improve health outcomes for diverse groups.
- Multidisciplinary team science (e.g., genetic risk assessments and genetic counseling).
Programs
- Connecting Underrepresented Populations to Clinical Trials (CUSP2CT)
- Contact CUSP2CT program staff at ncicusp2ct@nih.gov
- Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network Administrative Supplements Community Health Educator Supplement Program
- Administrative Supplements for the NCI P30 Cancer Center Support Grants for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
- Contact MICEO program staff at ncimiceo@mail.nih.gov